FLGT News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

FL

Mkt Cap

$546.5M

Volume

392.48K

Next Earnings

November 6th

Loading chart

FL

FLGTFulgent Genetics, Inc. Common Stock

FLGT

Pay with—

Available Balance0.00

FL

Mkt Cap

$545.1M

Volume

392.48K

Next Earnings

November 6th

Chart Financials Earnings News About Insider Filings

PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now?Both Precipio and Fulgent Genetics operate in specialty diagnostics with exposure to oncology, but Fulgent Genetics is recommended as the better investment choice. FLGT offers a more diversified growth platform through recent acquisitions (Bako Diagnostics, StrataDx), AI/digital pathology investments, and a therapeutic pipeline, while trading below its historical valuation median. PRPO shows improving fundamentals and cash generation but trades above its five-year median, suggesting its progress is already priced in.Zacks Investment Research · Sep 22, 2026

Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the FirmLaw firm Lowey Dannenberg is investigating Fulgent Genetics Inc. for potential violations of federal securities laws following the company's February 27, 2026 earnings report, which showed full year 2025 revenue of $322.7 million falling slightly short of updated guidance and sequential fourth quarter revenue decline. The firm is encouraging investors who suffered losses to contact them.GlobeNewswire Inc. · Apr 17, 2026

FLGT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws ViolationsKirby McInerney LLP is investigating Fulgent Genetics Inc. for potential securities law violations following a significant stock price decline. On February 27, 2026, Fulgent reported lower-than-expected 2026 guidance due to its largest customer moving work in-house, causing shares to drop 38.1% from $24.76 to $15.33. The law firm is seeking investors who purchased Fulgent securities to participate in the ongoing investigation.GlobeNewswire Inc. · Mar 20, 2026

Esoteric Testing Research Report 2026 - Global $41.5+ Bn Market Trends, Opportunities, and Forecasts to 2031The global esoteric testing market is projected to grow from $27.52 billion in 2025 to $41.56 billion by 2031 at a 7.11% CAGR, driven by rising chronic disease rates, personalized medicine demand, and liquid biopsy adoption. However, stringent regulatory frameworks and reimbursement pressures pose significant challenges to market expansion.GlobeNewswire Inc. · Jan 30, 2026

Why Fulgent Genetics Stock Was Crushing It on FridayFulgent Genetics reported Q2 earnings that exceeded analyst expectations, with revenue of $82 million, representing a 15% year-over-year increase, despite a 56% decrease in adjusted net income.The Motley Fool · Aug 1, 2025

Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, Adtran, and Fulgent and Encourages Investors to Contact the FirmLaw firm Bragar Eagel & Squire is investigating potential securities law violations by GoHealth, Semler Scientific, ADTRAN, and Fulgent Genetics, following DOJ investigations and financial reporting issues.GlobeNewswire Inc. · Jul 15, 2025

Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Abacus, GoHealth, and Fulgent and Encourages Investors to Contact the FirmLaw firm investigating potential securities law violations for four companies, including DOJ investigations and stock price declines related to alleged false claims and kickback schemes.GlobeNewswire Inc. · Jul 1, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGTPomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (FLGT) regarding potential false claims submitted under the Uninsured Program. The investigation follows Fulgent's disclosure in its annual report that it had received a civil investigative demand from the U.S. Department of Justice.GlobeNewswire Inc. · Jun 23, 2025

Bragar Eagel & Squire, P.C. Is Investigating Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. is investigating potential claims against Semler Scientific Inc., ADTRAN Holdings, Inc., and Fulgent Genetics, Inc. regarding alleged violations of federal securities laws and/or other unlawful business practices.GlobeNewswire Inc. · Jun 10, 2025

Bragar Eagel & Squire, P.C. Is Investigating EchoStar, Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. is investigating potential claims against EchoStar, Semler Scientific, ADTRAN Holdings, and Fulgent Genetics due to alleged violations of federal securities laws and other unlawful business practices.GlobeNewswire Inc. · Jun 3, 2025

to start trading

FL

FLGTFulgent Genetics, Inc. Common Stock

FLGT

Pay with—

Available Balance0.00

Your PositionYou don't own any FLGT yet.

Related Tickers

Earnings